Paul Cheng
- Cancer Research top 5%
- Molecular Biology top 10%
- Congenital heart defects research 9
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 5
- Health Informatics top 10%
- Oncology top 10%
- CAR-T cell therapy research 7
-
- Lymphoma Diagnosis and Treatment 10
-
- Chronic Lymphocytic Leukemia Research 9
- Connective tissue disorders research 5
-
- Aortic aneurysm repair treatments 6
- Aortic Disease and Treatment Approaches 6
- Co-authors
- Deepak SrivastavaChulan KwonVishal NigamThomas QuertermousPeter AndersenQian LiRobert WirkaRonald Witteles
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (6 papers)Circulation Research (4 papers)Circulation (3 papers)
- Partner nations
- United StatesHong KongChina
In The Last Decade
Paul Cheng
71 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 120
- Cancer Research 338
- Molecular Biology 1.1k
- Immunology 333
- Health Informatics 19
- Oncology 336
Countries citing papers authored by Paul Cheng
This map shows the geographic impact of Paul Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Cheng more than expected).
Fields of papers citing papers by Paul Cheng
This network shows the impact of papers produced by Paul Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Cheng. The network helps show where Paul Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 63 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 49 | |
| 16 | 2017 | 0 | |
| 17 | 2013 | 8 | |
| 18 | 2012 | 64 | |
| 19 | 2011 | 232 | |
| 20 | 1996 | 15 |
About Paul Cheng
Paul Cheng is a scholar working on Medical Terminology, Genetics and Pathology and Forensic Medicine, having authored 80 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Congenital heart defects research (9 papers), CAR-T cell therapy research (7 papers), Aortic aneurysm repair treatments (6 papers), Aortic Disease and Treatment Approaches (6 papers), Connective tissue disorders research (5 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). The work is most often cited by research in Cancer Research (338 citations), Molecular Biology (1.1k citations) and Immunology (333 citations). Paul Cheng has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Deepak Srivastava, Chulan Kwon, Vishal Nigam, Thomas Quertermous, Peter Andersen, Qian Li, Robert Wirka, Ronald Witteles, Lincoln T. Shenje and Isabelle N. King. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Circulation Research, Circulation, Journal of the American College of Cardiology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.